Anemia, a prevalent condition characterized by a decrease in the number of red blood cells or less than the normal quantity of hemoglobin in the blood, presents a diagnostic challenge due to its multifactorial etiology. This article aims to provide a comprehensive diagnostic approach to anemia in clinical practice.
The initial evaluation of anemia should include a thorough patient history and physical examination. The history should focus on potential causes such as dietary habits, family history, and symptoms like fatigue, pallor, or dyspnea. The physical examination should assess for signs of systemic diseases which could contribute to anemia.
Basic laboratory investigations should include a complete blood count (CBC) with peripheral smear, reticulocyte count, and serum ferritin. More specific tests such as Vitamin B12, folate levels, or hemoglobin electrophoresis may be indicated based on initial findings. An elevated red cell distribution width (RDW) can indicate a mixed cause of anemia or an early stage of a developing anemia.
Further diagnostic refinement should be guided by the initial investigations. Microcytic anemia may indicate iron deficiency, thalassemia, or anemia of chronic disease. Normocytic anemia could be due to renal disease, malignancy, or aplastic anemia. Macrocytic anemia might suggest Vitamin B12 or folate deficiency, myelodysplastic syndrome, or alcoholism. Bone marrow examination may be necessary in cases of unexplained anemia.
Anemia is a complex disorder with a broad differential diagnosis. A systematic approach that includes a thorough history, physical examination, and appropriate laboratory investigations can help clinicians navigate this complexity. Ongoing research into the pathophysiology of anemia continues to inform and refine our diagnostic approach, promising more precise and personalized care for patients with this common condition.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation